Back to Top Skip to main content

DoD, HHS implement Executive Order to modernize flu vaccines

Health care experts recommend that everyone 6 months and older – including the elderly, chronically ill people, and expectant mothers – receive the flu vaccine as soon as it becomes available. (DoD photo) Health care experts recommend that everyone 6 months and older – including the elderly, chronically ill people, and expectant mothers – receive the flu vaccine as soon as it becomes available. (DoD photo)

Recommended Content:

Immunization Healthcare | Immunizations

The Department of Defense and Department of Health and Human Services are implementing an Executive Order signed by President Donald Trump, aimed at increasing the manufacturing efficiency and effectiveness of flu vaccines.

The EO establishes the National Influenza Vaccine Task Force, which will include representatives from the Centers for Disease Control and Prevention as well as the departments of Justice, Agriculture, Veterans Affairs, Homeland Security, and Food and Drug Administration.

The task force is co-chaired by DoD and HHS. 

Modernizing flu vaccines in the United States is a matter of national security and public health, said Dr. Terry M. Rauch, acting deputy assistant secretary of Defense for Health Readiness Policy and Oversight. Rauch added that DoD is committed to collaborating with HHS and partner agencies.

“DoD acknowledges and supports the great need for flu vaccines to be rapidly responsive, flexible, scalable, and more effective at preventing the spread of flu viruses,” Rauch said.

The goal of the EO is to encourage federal departments and agencies and their stakeholders to implement and support modernizing U.S. flu vaccines. That means reducing reliance on egg-based flu vaccine production; expanding domestic capacity of alternative methods to allow more agile and rapid response to emerging flu viruses; and advancing development of new, broadly protective vaccines with longer lasting immunity.

The EO directs tasks for key organizations. The DoD's responsibilities include estimating the costs of transition to scalable, innovative technologies from domestic, manufacturers; coordinating with other agencies to conduct epidemiological studies of vaccine effectiveness; identifying opportunities to use DoD's vaccine research and development enterprise; and investigating innovative pathways to facilitate the development of next-generation flu vaccines.

Rauch said the efforts related to the EO "support the National Defense Strategy’s priority to advance readiness of the force, providing the best possible support to our warfighters on the battlefield and back home. The U.S. Congress, as well as the public, should remain confident that federal departments and agencies are working together to effectively address influenza as a threat."

The flu virus is common; approximately 49 million Americans were affected during the 2017-18 season, according to the CDC. Flu infections usually happen during the fall and winter, according to the CDC, with peak activity occurring between December and February. Most flu sufferers will experience effects for a few days to up to two weeks.

Some people, however, develop complications that can become life-threatening. The CDC estimates that for the 2017-18 flu season, 959,000 hospitalizations and 79,000 deaths were linked to influenza.

"Certain groups are at high risk of flu-related complications," said Dr. Jay Montgomery, medical director of the Defense Health Agency's North Atlantic Region Vaccine Safety Hub, Immunization Healthcare Division.

At-risk individuals include children ages 6 months to almost 5 years, adults 50 and older, people with chronic medical conditions, and pregnant women, Montgomery said, citing statistics from the CDC.

Health care experts recommend that everyone 6 months and older – including the elderly, chronically ill people, and expectant mothers -- receive the flu vaccine as soon as it becomes available. It's particularly important not only for individuals in the at-risk groups, but also for people who live with or care for them. The benefits of the vaccine far outweigh the risks of contracting the virus, health care experts say.

"Influenza is a specific threat to U.S. forces," Rauch said.

Active-duty, National Guard, and Reserve members are required to get the vaccine annually, Montgomery notes. Flu vaccination is also a requirement for DoD civilian health care personnel, said Tara Reavey, chief of policy and program management for DHA's Immunization Healthcare Division.

You also may be interested in...

A human vaccine for the Zika virus may be coming soon

Video
7/22/2016
A human vaccine for the Zika virus may be coming soon

Scientists at the Walter Reed Army Institute of Research in Silver Spring, Maryland, have developed a possible vaccine for the Zika virus.

Recommended Content:

Mosquito-Borne Illnesses | Zika Virus | Immunization Healthcare | Medical Research and Development

The HPV Vaccine Saves Lives

Infographic
5/16/2016
The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4). This graphic highlights information the benefits of the HPV vaccine. The vaccine is most effective among fully vaccinated individuals.   Cancer Prevention Facts •	HPV is the most common sexually  transmitted infection (STI) •	There are more than 40 HPV types that can infect the genital areas •	Some HPV types give warts •	Some HPV types develop cancer  Effective Against STI Transmission •	The HPV vaccine is a safe and effective way to protect yourself from the virus •	The HPV vaccine provides nearly 100% protection from HPV types 6,11,16 and 18 •	HPV vaccine shows early signs of success in reducing HPV infections and related illnesses •	Protection is expected to be long-lasting  Safety Tips •	Getting your HPV vaccine and practicing safe sex such as wearing a condom may lower the risk of HPV •	Limiting the number of lifetime sex partners can also lower the risk of HPV •	When given the HPV vaccine, the body makes antibodies in response to the protection to clear it from the body  Get the Facts •	2,091 female service members aged 17-26 years received 1-3 HPV4 doses during 2006-2012, stratified by number of doses (1, 2, or 3).  Get the HPV Vaccine •	Only 22.5% of eligible service members initiated the series •	Of those, only 39.1% completed the full three-dose series as of June 2011.  Even though the 3 dose regiment provides nearly complete protection against HPV16 and HPV18, in the U.S., only 12% and 19% of female adolescents among commercial and Medicaid plans respectively complete the series.  Read HPV Facts from the CDC: https://www.ok.gov/health2/documents/IMM_Teens_HPV_Facts.pdf  Read the STI issue of the Medical Surveillance Monthly Report at Health.Mil/MSMR   Get the conversation started. Ask your healthcare provider about the HPV vaccine today. Follow us on Twitter @AFHSBPAGE and use hashtag #VaccinesWork.

The Defense Department recommends male and female military service members, ages 17-26 years, receive an HPV vaccine series to generate a robust immune response to the quadrivalent human papillomavirus vaccine (HPV4).

Recommended Content:

Preventive Health | Immunizations | Men's Health | Human Papillomavirus | Armed Forces Health Surveillance Branch | Women's Health

Spread the Facts Not Your Germs

Infographic
12/8/2015
Infographic about protecting yourself from the flu

Protect yourself from the flu: Get vaccinated, Wash your hands, Sneeze and cough into your elbow, Stay at home if you're sick

Recommended Content:

Immunizations

Armed Services Blood Program Immunization List

Publication
3/24/2014

Armed Services Blood Program guidance on donor deferral (if any) after receiving immunizations.

Recommended Content:

Vaccine-Preventable Diseases | Vaccine Schedules | Immunization Healthcare

Immunizations and Chemoprophylaxis for the Prevention of Infectious Diseases

Policy
  • Identification #: Army Regulation 40–562 BUMEDINST 6230.15B AFI 48–110_IP CG COMDTINST M6230.4G
  • Date: 10/7/2013
  • Type: Instructions
  • Topics: Immunization Healthcare

Japanese Encephalitis (JE) virus is a mosquito-borne flavivirus and the most common vaccine-preventable cause of encephalitis in Asia

Policy

Individuals deploying to areas in Pacific Command (PACOM) should be administered the JE vaccine in accordance with the latest PACOM Force Health Protection Guidance.

Guidance on Medications for Prophylaxis of Malaria 13-002

Policy

This document provides guidance and best practices for the chemoprophylaxis (use of medication to prevent malaria) of Service members serving in malaria endemic regions.

Guideline for Tuberculosis Screening and Testing

Policy

Because accessions come from widely diverse geographic backgrounds, the Services should determine the need for tuberculin skin tests for accessions while Service members are at the training base, based on the needs of the specific accessions environment and operational mission requirements. DoD will implement targeted testing rather than universal testing where possible, based on Service-specific mission requirements, for recruits and new accessions, HCWs, recent deployers, and Service members who are retiring.

  • Identification #: 00-memo-2012-04-20
  • Date: 4/20/2012
  • Type: Memorandums
  • Topics: Immunizations

ACIP General Recommendations on Immunization

Report
1/28/2011

Recommended Content:

Immunization Healthcare

Routine Smallpox and Anthrax Immunizations Policies

Report
12/15/2010

Defense Health Board: Routine Smallpox and Anthrax Immunizations Policies

Recommended Content:

Immunization Healthcare | Immunizations | Deployment Health

Inclusion of the Measles Mumps and Rubella Vaccine

Report
12/11/2010

Defense Health Board: Inclusion of the Measles Mumps and Rubella Vaccine

Recommended Content:

Immunizations | Immunization Healthcare

Accomplishments and Critical Lessons Learned Regarding Department of Defense H1N1 Influenza Report

Presentation
11/2/2010

Accomplishments and Critical Lessons Learned Regarding Department of Defense H1N1 Influenza Report briefing presented to the Defense Health Board Nov. 2, 2010

Recommended Content:

Immunizations | Immunization Healthcare

Measles Mumps Rubella and Smallpox Anthrax Vaccine Recommendations

Presentation
8/18/2010

Measles Mumps Rubella and Smallpox Anthrax Vaccine Recommendations briefing presented to the Defense Health Board Aug. 18, 2010

Recommended Content:

Immunizations | Immunization Healthcare

Inclusion of Measles Mumps Rubella Vaccine in Navy Accessions Screening and Immunizations Program

Presentation
6/8/2010

Inclusion of Measles Mumps Rubella Vaccine in Navy Accessions Screening and Immunizations Program briefing presented to the Defense Health Board June 8, 2010

Recommended Content:

Immunizations | Immunization Healthcare

Joint Preventive Medicine Policy Group Response to the Pandemic Influenza Preparedness and Response

Presentation
3/1/2010

Joint Preventive Medicine Policy Group Response to the Pandemic Influenza Preparedness and Response briefing presented to the Defense Health Board March 1, 2010

Recommended Content:

Immunizations | Immunization Healthcare
<< < 1 2 3 4 5  ... > >> 
Showing results 46 - 60 Page 4 of 6

DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101

Some documents are presented in Portable Document Format (PDF). A PDF reader is required for viewing. Download a PDF Reader or learn more about PDFs.